Second Sight Medical Products, Inc. Announces Completion of Oversubscribed Rights Offering
SYLMAR, Calif.--(BUSINESS WIRE)--Second Sight Medical Products, Inc. (NASDAQ:EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics that provide some useful vision to blind patients, today announced that it has completed its previously announced rights offering to shareholders of record on February 10, 2017. The rights offering was oversubscribed. Second Sight will retain about $20.1 million of the subscriptions received, with subscript